Company intelligence / Profile preview

Somerset Therapeutics

Somerset, New Jersey, United Statessomersetlimited.com ↗

Ownership: Private
Development stage: Commercial

Overview

Somerset Therapeutics has six products currently on the market in the US. The company maintains a strong pipeline with approximately 25 additional products awaiting FDA approval. Its focus includes sterile injectable and ophthalmic generics for hospital and specialty use. The company’s manufacturing facilities are cGMP-compliant and have received regulatory approvals from agencies including the US FDA.

Therapeutic areas: OtherCardiovascularOphthalmologyInfectious Diseases
Modalities: Injectable drugsOphthalmic drugsOral solidsSmall molecule
Industry: Biotech

Drug pipeline

1 asset

Various injectables and ophthalmics

Commercial

Indications: Pain, Calcium deficiency, Nausea, Malaria, Anesthesia, Infection, Cardiovascular disease, Allergy, Iron deficiency, Glaucoma

Partnerships

Sanofi-AventisNovartisBayerAlcon US

Beyond the preview

Go deeper on Somerset Therapeutics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Somerset Therapeutics.

Explore the full profile